SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Surgical Innovation
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Gigot, J.F.
Right arrow Articles by Claeys, N.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Gigot, J.F.
Right arrow Articles by Claeys, N.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Present Status of Laparoscopic Splenectomy for Hematologic Diseases: Certitudes and Unresolved Issues

J.F. Gigot, MD, PhD

Department of Digestive Surgery, St-Luc University Hospital, Louvain Medical School, Brussels, Belgium

B. Lengele, MD, PhD

Department of Digestive Surgery, St-Luc University Hospital, Louvain Medical School, Brussels, Belgium

P. Gianello, MD, PhD

Department of Digestive Surgery, St-Luc University Hospital, Louvain Medical School, Brussels, Belgium

J. Etienne, MD

Department of Digestive Surgery, St-Luc University Hospital, Louvain Medical School, Brussels, Belgium

N. Claeys, MD

Department of Digestive Surgery, St-Luc University Hospital, Louvain Medical School, Brussels, Belgium

Laparoscopic splenectomy is considered to be the "gold-standard" treatment of benign hematologic diseases, with normal or slightly enlarged spleens. Laparoscopic treatment of malignant diseases and splenomegalies remains more controversial. The procedure requires a great surgeon's laparoscopic expertise, appropriate positioning of the patient and trocar insertion, and gentle and meticulous dissection of the spleen. The technique is feasible in 91 % of the patients with a 0.9% operative mortality and a postoperative complications rate of 12%. When compared with open splenectomy in retrospective case-controlled studies, the laparoscopic approach includes a longer operative time and higher operative room costs. However, advantages include reduced postoperative hospital stay and faster return to normal activities. Despite scarce reported data, long-term hematologic cure rate seems to be equivalent in patients with idiopathic thrombocytopenic purpura. The accuracy of laparoscopic exploration to detect all accessory spleens is however questioned, and residual postoperative accessory splenic tissues have been observed. Prospective randomized controlled trials comparing short- and long-term results of open and laparoscopic splenectomies are required to confirm definitely the role of laparoscopy in the management of hematologic disorders. Copyright© 1998 by W B. Saunders Company

Key Words: Splenectomy • laparoscopy • hematologic disease • accessory spleen • idiopathic thrombocytopenic purpura.

Surgical Innovation, Vol. 5, No. 3, 147-167 (1998)
DOI: 10.1177/155335069800500302


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement